Literature DB >> 11824797

Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index.

Mitsuru Seo1, Mitsuo Okada, Tsuneyoshi Yao, Hiroaki Matake, Kazuhiro Maeda.   

Abstract

BACKGROUND: Because it is not easy to make a clinical decision regarding surgical treatment in patients with acute attacks of ulcerative colitis, an objective, simple, criterion is needed to determine the optimum timing for colectomy. The aim of this study was to retrospectively examine to what extent an activity index (AI) can evaluate the clinical course in such acute attacks.
METHODS: One hundred and twenty-seven patients with moderate or severe attacks of ulcerative colitis were examined. AI values and the decline in AI values were compared between surgical and nonsurgical groups after 1 week and 2 weeks of medical therapy. To evaluate the clinical course of acute attacks, cutoff AI values were set at every 10 points between values of 180 and 210. The positive predictive value for surgery was examined.
RESULTS: AI values in the surgical group were significantly higher than those in nonsurgical group at pretreatment, and after 1 or 2 weeks of medical therapy. The decline of AI values in the nonsurgical group was significantly higher than that in the surgical group after 1 or 2 weeks of medical therapy. At pretreatment, the prediction of colectomy was less than 50% at any of the cutoff values. After 1 week of therapy, approximately 60% of patients with an AI value greater than any of the cutoff AI values required colectomy. After 2 weeks of therapy, 30 of 43 (70%), 28 of 38 (74%), 24 of 29 (83%), and 17 of 21 (81%) patients with AI values greater than 180, 190, 200, and 210, respectively, required colectomy. Overall accuracy was 86%, 87%, 88%, and 83% for cutoff AI values of 180, 190, 200, and 210, respectively. Because the overall accuracy and positive predictive value for colectomy at AI values of 200 were significantly higher than these parameters at other AI values after 2 weeks of therapy, an AI value of 200 was regarded as the cutoff value most able to predict colectomy.
CONCLUSIONS: We concluded that patients with an AI value in excess of 200 after 2 weeks of medical therapy would require surgical treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824797     DOI: 10.1007/s535-002-8129-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  10 in total

1.  Corticosteroid therapy in ulcerative colitis: Clinical response and predictors.

Authors:  Jin Li; Fan Wang; Hong-Jie Zhang; Jian-Qiu Sheng; Wen-Feng Yan; Min-Xing Ma; Ru-Ying Fan; Fang Gu; Chuan-Feng Li; Da-Fan Chen; Ping Zheng; Yu-Pei Gu; Qian Cao; Hong Yang; Jia-Ming Qian; Pin-Jin Hu; Bing Xia
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis.

Authors:  Han Ho Jeon; Hyun Jung Lee; Hui Won Jang; Jin Young Yoon; Yoon Suk Jung; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 3.  Role of surgery in severe ulcerative colitis in the era of medical rescue therapy.

Authors:  Bosmat Dayan; Dan Turner
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

4.  Infliximab: the evidence for its place in therapy in ulcerative colitis.

Authors:  Gert Van Assche; Séverine Vermeire; Paul Rutgeerts
Journal:  Core Evid       Date:  2008-02-29

5.  Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.

Authors:  Marco M Hefti; David B Chessin; Noam H Harpaz; Randolph M Steinhagen; Thomas A Ullman
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

Review 6.  Steroid-refractory severe ulcerative colitis: what are the available treatment options?

Authors:  Alan C Moss; Mark A Peppercorn
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.

Authors:  Joseph D Feuerstein; Kim L Isaacs; Yecheskel Schneider; Shazia Mehmood Siddique; Yngve Falck-Ytter; Siddharth Singh
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

8.  AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.

Authors:  Siddharth Singh; Jessica R Allegretti; Shazia Mehmood Siddique; Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

9.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

Review 10.  Second Korean guidelines for the management of ulcerative colitis.

Authors:  Chang Hwan Choi; Won Moon; You Sun Kim; Eun Soo Kim; Bo-In Lee; Yunho Jung; Yong Sik Yoon; Heeyoung Lee; Dong Il Park; Dong Soo Han
Journal:  Intest Res       Date:  2017-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.